메뉴 건너뛰기




Volumn 15, Issue 15, 2013, Pages 2822-2834

Chloramphenicol·cyclodextrin inclusion compounds: Co-dissolution and mechanochemical preparations and antibacterial action

Author keywords

[No Author keywords available]

Indexed keywords


EID: 84875627557     PISSN: None     EISSN: 14668033     Source Type: Journal    
DOI: 10.1039/c3ce26414a     Document Type: Article
Times cited : (66)

References (71)
  • 4
    • 49849086286 scopus 로고    scopus 로고
    • World Health Organization, Standardized Treatment of Bacterial Meningitis in Africa in Epidemic and Non-Epidemic Situations, Geneva, World Health Organization, 2007
    • M. Scarborough G. E. Thwaites Lancet Neurol. 2008 7 637 648
    • (2008) Lancet Neurol. , vol.7 , pp. 637-648
    • Scarborough, M.1    Thwaites, G.E.2
  • 7
    • 84876714472 scopus 로고
    • See for example, Cyclodextrin Inclusion Compound of Medicine Having Improved Solubility-Obtd. by Roll Mixing Powder of e.g. Hydroxybenzoic Acid and Cyclodextrin Powder, in Anhydrous Conditions, Yamamouchi Pharm. Co. Ltd, Derwent Primary Accession Number
    • See for example, Cyclodextrin Inclusion Compound of Medicine Having Improved Solubility-Obtd. by Roll Mixing Powder of e.g. Hydroxybenzoic Acid and Cyclodextrin Powder, in Anhydrous Conditions, Jp. Pat., JP2279631-A, Yamamouchi Pharm. Co. Ltd, 1991, Derwent Primary Accession Number, 1991-003131
    • (1991) Jp. Pat., JP2279631-A , pp. 1991-003131
  • 27
    • 84876716340 scopus 로고
    • Derwent Primary Accession Number
    • A. Hedges and F. Tenbarge, US Pat. 5007966-A, 1991, Derwent Primary Accession Number, 1991-132180
    • (1991) US Pat. 5007966-A , pp. 1991-132180
    • Hedges, A.1    Tenbarge, F.2
  • 38
    • 41549130904 scopus 로고    scopus 로고
    • Version 1.451, Oxford Cryosystems, Oxford, United Kingdom
    • Cryopad Remote monitoring and control, Version 1.451, Oxford Cryosystems, Oxford, United Kingdom, 2006
    • (2006) Cryopad Remote Monitoring and Control
  • 40
    • 0003423563 scopus 로고    scopus 로고
    • Bruker/Siemens Area Detector Absorption Correction Program, Bruker AXS, Madison, Wisconsin, USA
    • G. M. Sheldrick, SADABS v.2.01, Bruker/Siemens Area Detector Absorption Correction Program, Bruker AXS, Madison, Wisconsin, USA, 1998
    • (1998) SADABS v.2.01
    • Sheldrick, G.M.1
  • 56
    • 0041469888 scopus 로고    scopus 로고
    • Considering that dimeric βCD inclusion compounds may also crystallise in the triclinic P1 space group and that microcrystals from this group were observed on powder X-ray diffraction studies on several batches of the material (see previous sub-sections), an attempt to model the geometry of the guest molecules was carried by performing structure solution and refinement for the corresponding triclinic unit cell: a = 15.467(4) Å, b = 15.557(5) Å, c = 15.735(4) Å, α = 101.78(1)°, β = 101.81(1)°, γ = 104.12(1)°. The resulting P1 structural model confirmed, once again, the presence of highly disordered guest molecules inside the cavities. To significantly improve the performance of the theoretical calculations the higher symmetry crystal solution of the host species was utilised
    • M. R. Caira Rev. Roum. Chim. 2001 46 371 386
    • (2001) Rev. Roum. Chim. , vol.46 , pp. 371-386
    • Caira, M.R.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.